Type 2 · Organization ✓ Active NPI ✓ Valid NPI checksum Organization subpart

Bio-Medical Applications of Texas, Inc.

End-Stage Renal Disease (ESRD) Treatment Clinic/Center in Texas City, TX · enumerated 2018 · authorized official Mark Fawcett, Senior Vice President & Treasurer.

Data current as of Jul 13, 2026 · sourced from CMS NPPES

National Provider Identifier

1376010785

Verified

See something wrong? Report a correction

Registry record

Entity type Organization (Type 2)

Legal business name Bio-Medical Applications of Texas, Inc.

Parent organization Fresenius Medical Care Holdings, Inc.

Practice address 8900 Emmett F Lowry Expy Ste 201, Texas City, TX, 77591

Phone (409) 933-0406

Enumeration date Oct 24, 2018

Last updated in NPPES Oct 24, 2018

Taxonomy & classification

261QE0700X End-Stage Renal Disease (ESRD) Treatment Clinic/Center Ambulatory Health Care Facilities Primary

Authorized official

Name Mark Fawcett

Title Senior Vice President & Treasurer

Phone (781) 699-9000

What is an NPI number?

A National Provider Identifier (NPI) is a unique 10-digit number that CMS assigns to every U.S. healthcare provider and organization under HIPAA. Type 1 NPIs identify individual providers; Type 2 NPIs identify organizations. The NPI appears on insurance claims, prescriptions, and credentialing paperwork, and never changes, even if the provider moves or changes specialty.

Read the full guide → Validate an NPI →

Frequently asked questions

How current is this record?

Data comes from the CMS NPPES public dissemination file; this record was last updated in NPPES on 2018-10-24. Verify at npiregistry.cms.hhs.gov.

Where is Bio-Medical Applications of Texas, Inc. located?

The practice location on file with NPPES is in Texas City, TX.

Providers at this address

Browse all →

Fresenius Medical Care Greater Southeast Houston, LLC End-Stage Renal Disease (ESRD) Treatment Clinic/Center · Texas City, TX NPI 1497352371

Source: CMS NPPES (public data). Snapshot 2026-07-13. Provider record last updated 2018-10-24.